This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment
Cellular & Molecular Immunology Open Access 05 April 2018
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Rosser EC, Mauri C . Regulatory B cells: origin, phenotype, and function. Immunity 2015; 42: 607–612.
Garaud S, Taher TE, Debant M, Burgos M, Melayah S, Berthou C et al. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes. Cell Mol Immunol 2016; e-pub ahead of print 8 August 2016; doi:10.1038/cmi.2016.42.
Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK . Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16: 219–230.
Schwartz M, Zhang Y, Rosenblatt JD . B cell regulation of the anti-tumor response and role in carcinogenesis. J Immunother Cancer 2016; 4: 40.
Liu J, Wang H, Yu Q, Zheng S, Jiang Y, Liu Y et al. Aberrant frequency of IL-10-producing B cells and its association with Treg and MDSC cells in non small cell lung carcinoma patients. Hum Immunol 2016; 77: 84–89.
Cai C, Zhang J, Li M, Wu ZJ, Song KH, Zhan TW et al. Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma. Tumour Biol 2016; 37: 8209–8218.
Ganti SN, Albershardt TC, Iritani BM, Ruddell A . Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth. Sci Rep 2015; 5: 12255.
Pylayeva-Gupta Y, Das S, Handler JS, Hajdu CH, Coffre M, Koralov SB et al. IL35-producing B cells promote the development of pancreatic neoplasia. Cancer Dis 2016; 6: 247–255.
Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 2015; 521: 94–98.
Ouyang FZ, Wu RQ, Wei Y, Liu RX, Yang D, Xiao X et al. Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma. Nat Commun 2016; 7: 13453.
Kuang DM, Zhao Q, Xu J, Yun JP, Wu C, Zheng L . Tumor-educated tolerogenic dendritic cells induce CD3epsilon down-regulation and apoptosis of T cells through oxygen-dependent pathways. J Immunol 2008; 181: 3089–3098.
Vomhof-DeKrey EE, Yates J, Hagglof T, Lanthier P, Amiel E, Veerapen N et al. Cognate interaction with iNKT cells expands IL-10-producing B regulatory cells. Proc Natl Acad Sci USA 2015; 112: 12474–12479.
Mion F, D’Inca F, Danelli L, Toffoletto B, Guarnotta C, Frossi B et al. Mast cells control the expansion and differentiation of IL-10-competent B cells. J Immunol 2014; 193: 4568–4579.
Qian L, Qian C, Chen Y, Bai Y, Bao Y, Lu L et al. Regulatory dendritic cells program B cells to differentiate into CD19hiFcgammaIIbhi regulatory B cells through IFN-beta and CD40L. Blood 2012; 120: 581–591.
Villa-Morales M, Fernandez-Piqueras J . Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets 2012; 16: 85–101.
Acknowledgements
Authors are supported by the Associazione Italiana Ricerca sul Cancro (AIRC), Progetti di Ricerca di Interesse Nazionale (PRIN), and Associazione Italiana Mastocitosi (ASIMAS).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Mion, F., Tonon, S., Valeri, V. et al. Message in a bottle from the tumor microenvironment: tumor-educated DCs instruct B cells to participate in immunosuppression. Cell Mol Immunol 14, 730–732 (2017). https://doi.org/10.1038/cmi.2017.63
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2017.63
This article is cited by
-
Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
Cellular & Molecular Immunology (2019)
-
Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment
Cellular & Molecular Immunology (2019)